Yazoume Ye et al | 15 Jul 2009 | Malaria Journal
In sub-Saharan Africa, knowledge of malaria transmission across rapidly proliferating urban centres and recommendations for its prevention or management remain poorly defined.
Roger Bate et al | 23 Jun 2009 | PLoS One
A pilot study was conducted in two major cities in India, Delhi and Chennai, to explore the question/hypothesis/extent of substandard and counterfeit drugs available in the market and to discuss how the Indian state and federal governments could improve drug regulation and more importantly regulatory enforcement to combat these drugs.
Elizeus Rutebemberwa et al | 12 Jun 2009 | Malaria Journal
Community distribution of anti-malarials and antibiotics has been recommended as a strategy to reduce the under-five mortality due to febrile illnesses in sub-Saharan Africa. However, drugs distributed in these interventions have been considered weak by some caretakers and utilization of community medicine distributors has been low.
Mwinyi Msellem et al | 28 Apr 2009 | PloS Medicine
The use of rapid diagnostic tests (RDTs) for Plasmodium falciparum malaria is being suggested to improve diagnostic efficiency in peripheral health care settings in Africa.
Roger Bate, Richard Tren, Kimberly Hess, Lorraine Mooney & Karen Porter | 27 Apr 2009 | African Journal of Pharmacy and Pharmacology
Researchers procured a range of antimalarial, antibiotic and antimycobacterial drugs from cities in six countries: Ghana, India, Kenya, Nigeria, Tanzania, and Uganda. Semi-quantitative thin-layer chromatography (TLC) and disintegration tests, Raman spectrometry, and near-infrared (NIR) spectrometry were used to measure the concentration of active ingredients and excipients (spectrometry only) to determine whether the tested samples were of good quality.
None | 21 Apr 2009 | Africa Fighting Malaria
Roll Back Malaria's theme for World Malaria Day 2009 is "Counting Malaria Out". AFM supports the Roll Back Malaria Partnership in their efforts to improve data collection and track progress of malaria control efforts. For the past year, AFM and its partners have focused on "counting out" poor-quality antimalarial drugs.
Joan Nankabirwa et al | 16 Apr 2009 | Malaria Journal
In Uganda, like in many other countries traditionally viewed as harbouring very high malaria transmission, the norm has been to recommend that febrile episodes are diagnosed as malaria. In this study, the policy implications of such recommendations are revisited.
Sarah G Staedke et al | 14 Apr 2009 | The Lancet
Home management of malaria—the presumptive treatment of febrile children with antimalarial drugs—is advocated to ensure prompt effective treatment of the disease. We assessed the effect of home delivery of artemether-lumefantrine on the incidence of antimalarial treatment and on clinical outcomes in children from an urban setting with fairly low malaria transmission.
Lucy A. Smith et al | 16 Mar 2009 | American Journal of Tropical Medicine and Hygiene
Effective case management of uncomplicated malaria is a cornerstone of successful malaria control. With current calls for the global elimination of malaria, all strategies to control malaria need to reach the highest achievable level of effective implementation.
Sodiomon B Sirima et al | 16 Mar 2009 | Malaria Journal
Artesunate (AS) plus amodiaquine (AQ) is one artemisinin-based combination (ACT) recommended by the WHO for treating Plasmodium falciparum malaria. Fixed-dose AS/AQ is new, but its safety and efficacy are hitherto untested.